A biotechnology company that uses gene therapy to treat neurodegenerative diseases.
Celosia Therapeutics has raised $16.8M in total funding. The most recent round was Series A. The last funding was announced in November 2024.
Celosia Therapeutics's investors include Uniseed.
Celosia Therapeutics is headquartered in Sydney, Australia.
A biotechnology company that uses gene therapy to treat neurodegenerative diseases.
Celosia Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Celosia Therapeutics — Funding & Investors." VCBacked, November 27, 2024, https://www.vcbacked.co/company/celosia-therapeutics. Accessed September 2, 2026.
VCBacked. (2024). Celosia Therapeutics — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/celosia-therapeutics
{{cite web |title=Celosia Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/celosia-therapeutics |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated